Pfizer has lagged behind the broader market over the past year, but analysts maintain a cautiously optimistic outlook on the ...

The deal would give GSK the rights to develop the drug for HRS-9821 and 11 preclinical programmes owned by Jiangsu Hengrui ...

ET Net News Agency, 29 July 2025] SIMCERE PHARMA (02096) rose 9.8% to HK$14.28. It hits an intra-day high of HK$14.28, hitting a historical high, and an intra-day low of HK$13.1. The total shares ...